Grip Strength Thresholds Predict Short-Term Mortality Risk in Mexican Older Adults

A simple handshake-style squeeze of a dynamometer may soon become one of the most cost-effective tools for spotting older adults at elevated risk of dying within just a few years. A new study published in European Geriatric Medicine has derived sex-specific handgrip strength thresholds for Mexican adults aged 50 and older, and then validated those cutoffs in an entirely separate, non-overlapping sample drawn from the same national research platform. The resulting numbers are strikingly concrete: men whose grip strength measured 28 kilograms or less, and women whose grip measured 18 kilograms or less, faced significantly higher short-term mortality than their stronger peers.

The research, led by Enrique Díaz de León González and colleagues at the Instituto Mexicano del Seguro Social in Monterrey, together with Hugo Gutiérrez Hermosillo of the Universidad Nacional Autónoma de México, addresses a persistent gap in geriatric medicine. Handgrip strength is measured routinely around the world as an indicator of overall muscle function, and it is embedded in sarcopenia diagnostic criteria and frailty assessments. Yet the specific cutoff values used to define weakness vary enormously across countries, ethnic groups, and study designs. A threshold derived from British, Korean, or Chinese populations may simply not apply to a Mexican woman in her seventies living in Guadalajara or a Mexican man in his eighties in a rural village.

To build locally relevant benchmarks, the team turned to the Mexican Health and Aging Study, known as MHAS, a nationally representative longitudinal survey of aging in Mexico that has followed cohorts of adults aged 50 and older since 2001. For the derivation phase, the researchers analyzed MHAS participants from the 2012 wave who had valid handgrip measurements and could be tracked for mortality through 2015. That derivation cohort ultimately included 1,922 participants, of whom 95, or 4.9 percent, died during the follow-up window.

The analytical approach relied on receiver operating characteristic analysis, a statistical technique that evaluates how well a continuous measure such as grip strength discriminates between those who experience an outcome, in this case death, and those who do not. From the resulting curves, the researchers selected cutoffs using Youden’s index, a standard method that maximizes the combined sensitivity and specificity of a diagnostic threshold. Handgrip strength showed acceptable discrimination overall, with an area under the curve of 0.7219, and the performance was even stronger when sexes were analyzed separately, reaching 0.7806 in men and 0.7347 in women. The optimal thresholds that emerged were 28 kilograms or less for men and 18 kilograms or less for women.

Deriving a threshold, however, is only half the scientific story. The history of clinical prediction research is littered with models and cutoffs that performed beautifully in the dataset used to create them but failed when applied to new populations, a phenomenon statisticians call overfitting. External validation, testing a derived tool in a fresh sample, is widely recognized as an essential but frequently skipped step. Notably, large reviews of prediction model literature have found that external validation of newly developed prognostic tools is infrequent, and when it is performed, the results often reveal worse discrimination than originally reported.

The Mexican team confronted this challenge directly by applying their derived cutoffs, unchanged, to a primary non-overlapping validation sample from Mex-Cog, the cognitive aging ancillary study linked to MHAS. This validation cohort of 966 adults was assessed in 2016, with mortality tracked through 2018 as a fixed-horizon binary outcome. During that period, 55 participants died. The question was whether grip strength at or below the newly derived sex-specific thresholds would still flag elevated mortality risk in a group of people who had played no role in shaping those thresholds.

The answer was yes. After adjusting for age and sex, participants whose grip strength fell at or below the thresholds had roughly 2.3 times the odds of death compared with stronger individuals, an odds ratio of 2.33 with a confidence interval extending from 1.15 to 4.73. When the researchers expanded the model to include additional complete-case covariates, the association remained robust, with an odds ratio of 2.13 and a confidence interval of 1.02 to 4.43. The persistence of the signal across both statistical specifications strengthens the argument that the effect is not an artifact of confounding by basic demographics alone.

The findings align with a substantial international literature linking grip strength to survival. The landmark PURE study, which followed more than 139,000 adults across 17 countries, found grip strength to be a stronger predictor of cardiovascular and all-cause mortality than systolic blood pressure. Analyses of half a million UK Biobank participants, meta-analyses encompassing roughly two million men and women, and cohort studies from Korea, Taiwan, and the United States have all reported similar associations. Research among older Mexican Americans, a population closely related to the Mexican cohort studied here, previously demonstrated that weaker grip predicts both mortality and disability over multi-year horizons. What the new study adds is a calibrated, locally derived threshold designed specifically for a short-term mortality horizon in the Mexican population itself.

The authors are careful to frame the practical interpretation of their results. The thresholds, they emphasize, should be viewed as practical markers of vulnerability rather than stand-alone predictors of individual mortality. Grip strength at or below the cutoff identifies a person who deserves closer clinical attention, a more comprehensive geriatric evaluation, and perhaps interventions targeting nutrition, physical activity, and underlying disease, but it does not doom any individual patient. This nuance matters because grip strength reflects a composite of muscle mass, neural drive, chronic inflammation, nutritional status, and general physiological reserve, making it a sensitive barometer of overall health rather than a cause of death in itself.

There is also a broader methodological message embedded in the work: handgrip strength thresholds used in geriatric assessment should be interpreted according to the target population, the outcome of interest, and the clinical purpose at hand. A cutoff optimized to detect low muscle mass will differ from one optimized to predict falls, disability after hip fracture, postoperative complications, or, as in this study, death within roughly three years. The same research group has previously published grip thresholds for predicting independent walking after hip fracture surgery and for stratifying the relationship between depressive symptoms and long-term mortality, underscoring that a single universal number is unlikely to serve every clinical question. Global normative data compiled by Dodd’s and colleagues show grip strength varying substantially across world regions, reinforcing the case for population-specific calibration.

The implications for practice are potentially significant, particularly in health systems with limited resources. A hand dynamometer costs a small fraction of laboratory panels or imaging studies, requires seconds to administer, and demands minimal training. Community health workers, primary care physicians, and even non-clinical staff can administer the test in homes, clinics, or survey settings. In a country like Mexico, where the population is aging rapidly and the MHAS platform has documented rising burdens of chronic disease and disability among older adults, an inexpensive triage tool that reliably flags individuals at heightened short-term mortality risk could help direct scarce preventive and geriatric services toward those most likely to benefit.

Certain limitations warrant attention. The validation cohort, while methodologically clean, included 966 participants and 55 deaths, meaning the confidence intervals around the validated effect are wide and the precision of the estimate is modest. Mortality in the validation phase was assessed over a fixed horizon rather than with continuous survival modeling, and residual confounding by unmeasured illness severity cannot be excluded in an observational secondary analysis. The thresholds also pertain to Mexican adults aged 50 and older and should not be exported wholesale to other populations without fresh validation, precisely the lesson the study itself teaches.

Even so, the study represents a model of translational geriatric epidemiology: derive locally, validate independently, and report honestly. As populations across Latin America, Asia, and Africa age faster than their health systems can traditionally adapt, low-cost performance measures calibrated to local populations will become increasingly central to risk stratification. A grip of 28 kilograms for men and 18 kilograms for women may look like unremarkable numbers on a dynamometer dial, but in Mexico they now carry a clinically meaningful message about who needs attention soon.

Subject of Research: Derivation and validation of sex-specific handgrip strength thresholds for short-term mortality risk stratification in Mexican adults aged 50 and older

Article Title: Sex-specific handgrip strength thresholds for short-term mortality risk stratification in Mexican older adults: derivation in MHAS and validation in Mex-Cog

Article References: Díaz de León González, E., García Cavazos, H. E., Ibarra Hernandez, A. C., Culebro Perez, A. D., Guevara Alcalá, M. N., Martinez De León, A., & Gutiérrez Hermosillo, H. (2026). Sex-specific handgrip strength thresholds for short-term mortality risk stratification in Mexican older adults: derivation in MHAS and validation in Mex-Cog. European Geriatric Medicine. https://doi.org/10.1007/s41999-026-01611-x

Image Credits: AI Generated

DOI: 10.1007/s41999-026-01611-x

Keywords: handgrip strength, mortality, older adults, geriatrics, Mexico, MHAS, Mex-Cog, sarcopenia, risk stratification, validation, frailty, muscle weakness